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ABSTRACT
1
ANCA-positive vasculitis, leukopenia, and levamisole contaminated cocaine: Case
series and emerging patterns
1 - J. Harp, 2 - L. Fox, 3 - T. Maurer 1-3 University of California San Francisco
Over the last year several reports have postulated levamisole contaminated cocaine as a cause of
retiform purpura and agranulocytosis. Levamisole was used in the past as an antihelmintic and
immunomodulator with reported side effects including agranulocytosis and cutaneous purpura.
According to the DEA, in July 2009 69% of cocaine was contaminated with levamisole. We
present a case series of seven patients with retiform purpura, leukopenia, and a history of cocaine
use in order to further classify this emerging disease. All 7 patients were women, aged 33 to 50,
who presented from March 2009 to September 2010. They were all found to have retiform
purpura most often on the legs (7 of 7) and ear (4 of 7). All 7 patients had a skin biopsy consistent
with leukocytoclastic vascuiltis with thrombi. One patient had 2 additional biopsies, one with
LCV only, the other with thrombosis only. A DIF was positive in 2 of 4 biopsies both for
perivascular C3. All 7 patients had positive ANCAs. In 2 patients, elevated ANCA titers were
noted, but specific testing for cANCA and pANCA was not performed. Of the remaining 5, 1 was
positive for cANCA, 2 were positive for pANCA, and 2 were positive for both. Of note, 2 of the
patients had very high ANCA titers of 1:20,480. All patients were found to be leukopenic with 5 of
7 being neutropenic. 6 patients underwent a hypercoaguable work-up and all 6 had positive a
anticardiolipin IgM (negative IgG). In addition, all 6 had a lupus anticoagulant present either by
RVVT or hexa. Beta-2-glycoprotein IgM was positive in 2 of the 3 patients tested. Other notable
findings included an elevated ESR and/or CRP in all 7 patients. None of the patients had a
significant elevation in creatinine over baseline or evidence of sustained transaminitis. 6 of the 7
patients had positive ANA titers ranging from 1:80 to 1:640 (3 diffuse pattern, 3 speckled). Striking
patterns emerge in these 7 patients including retiform purpura, skin biopsy with LCV and thrombi,
ANCA positivity, neutropenia or leukopenia, and positive anticardiolipin IgM and lupus
anticoagulant. Interestingly, 2 of the patients had a history of possible anti-phospholipid antibody
syndrome prior to their presentation and a third had a known diagnosis of systemic lupus
erythematosus. Therefore, we postulate that this unusual reaction pattern is a result of an
underlying or tendency toward hypercoaguability that is unmasked upon exposure to levamisole.
2
Low prevalence of necrolytic acral erythema in patients with chronic hepatitis C
virus infection
1- BA Raphael/2-ZL Dorey-Stein/2-V Lo Re III/1-C Kovarik 1-Department of Dermatology,
University of Pennsylvania School of Medicine/2- Division of Infectious Diseases, Department of
Medicine, University of Pennsylvania School of Medicine
Chronic hepatitis C virus (HCV) infection is associated with several dermatologic diseases,
including necrolytic acral erythema (NAE). Previous studies among chronic HCV patients in Egypt
have noted that NAE may be the first sign of chronic HCV infection. The prevalence and clinical
features of NAE among chronic HCV patients remain unknown. Objective: To determine the
prevalence and characteristics of NAE in patients with chronic HCV. Methods: We performed a
multicenter prevalence study among chronic HCV patients. Subjects with quantifiable HCV RNA
in serum were recruited from viral hepatitis clinics of 3 Philadelphia hospitals. Patients underwent
a dermatologic examination and completed a questionnaire collecting demographic and clinical
data. Laboratory data were collected from medical records. Among patients with skin findings
consistent with NAE, skin biopsies were performed and the diagnosis confirmed by a
dermatopathologist. Results: Among 226 patients with chronic HCV infection (median age, 55
years; 74% male; 71% HCV genotype 1), 3 (1.3%; 95% CI, 0.3 – 3.8%) had NAE confirmed by
skin biopsy. Among all three subjects, skin biopsies demonstrated variable psoriasiform
hyperplasia, mild papillomatosis, spongiosis, parakeratosis, and necrotic keratinocytes in the
epidermis. All 3 patients were 450 years old, African American males, infected with HCV
genotype 1 and had a high viral load (4800,000 IU/mL). Patient one had diabetes mellitus and
was infected with human immunodeficiency virus infection (HIV; CD4 cell count ¼ 901 cells/
mm3). Patient two was also HIV-infected (CD4 cell count ¼ 270 cells/mm3). Patient three was
identified with hepatic decompensation and expired shortly after enrollment from hepatocellular
carcinoma (HCC). Conclusion: The prevalence of NAE among chronic HCV patients in this
sample was very low. It is possible that this finding is attributed to the specific HCV genotype seen
in distinct geographic areas. Further research is needed to identify the etiology of NAE.
3
Assessor-blinded study of the metabolic syndrome and surrogate markers of
increased cardiovascular risk in children with moderate to severe psoriasis
compared with age matched population of children with warts
1- Andrew C Wang MD, 1-Todd A Kerensky MD, 1-Shiu-Chung Au MD, 1-Nicole Dumont,
2-Shimrat Yaniv, 3-Manasa Bhandarkar, 4-Eva M. Volf, 4-Danielle E. Levine, 1-Eshan Patvardhan
MBBS, 1-Kevin Heffernan PhD, 4-Ari Goldminz, 4-Ashley Sekhon, 1-Daniel S. Loo MD, 1-Jeffrey
Kuvin MD, 1-Christina Pelajo MD, 1-Jorge Lopez MD, 1-Alice B. Gottlieb MD, PhD, 1-Tufts
Medical Center, Boston, MA/ 2-Albert Einstein College of Medicine, New York, NY/3-Brandeis
University, Waltham, MA/4-Tufts University School of Medicine, Boston, MA
Adult patients with psoriasis have an increased prevalence of the metabolic syndrome and
cardiovascular disease (CVD) risk factors due to elevations of TNF and other inflammatory
cytokines. However, the prevalence of the MetS and risk factors for CVD in children with
psoriasis is unknown. We designed an assessor blinded study to determine if children with
psoriasis have an increased prevalence of metabolic syndrome and surrogate factors for increased
CVD risk in twenty children, ages 10-17 with moderate to severe psoriasis (present or history of
Z5% BSA) compared with twenty age-matched children with warts. Metabolic syndrome was
defined by the presence of three of the following criteria: triglycerides Z100mg/dl, HDL-C
o50mg/dl for females or o45mg/dl males, fasting blood glucose Z110mg/dl, waist
circumference 475th percentile for age and sex, systolic or diastolic blood pressure 490th
percentile for age, sex, and height. Serum lipid profiles were obtained after 12-hour fast.
Preliminary results of 18 enrolled children showed that children with psoriasis had lower mean
HDL-C levels, 41.7mg/dl versus 53.8mg/dl in the control group (p¼ 0.048). Although not
statistically significant, one third of pediatric psoriasis patients met criteria for metabolic
syndrome versus no children in the control group (p¼ 0.245).
4
Diagnostic guidelines for cellulitis: Recommendations based on a retrospective
analysis of cellulitis admissions to Massachusetts General Hospital
1-EE Bailey/2-D Kroshinsky 1-Columbia University College of Physicians and Surgeons, New
York, NY/2-Department of Dermatology, Massachusetts General Hospital, Boston, MA
Cellulitis is a common cause of outpatient visits and inpatient admission in the U.S. A significant
portion of cases initially diagnosed as cellulitis may actually represent other dermatologic or systemic
conditions. Diagnosis is currently limited by a lack of well-defined, evidence-based criteria. The
purpose of this study is to propose diagnostic guidelines to increase the specificity of cellulitis
diagnosis in the inpatient setting, based on retrospective analysis of cellulitis admissions at a single
institution. All cases admitted to Massachusetts General Hospital between April 1, 2009 and
September 30, 2009 with ICD-9 codes 681.0, 681.1, and 682, designating ‘‘cellulitis or abscess’’ of
any anatomic site, were reviewed. Cases of abscess, human or animal bite, burn, hardware infection,
line infection, arteriovenous fistula infection, and osteomyelitis secondary to chronic infection were
excluded. The predictive value of clinical characteristics and laboratory results for distinguishing true
cellulitis from ‘pseudo’ cellulitis was evaluated using logistic regression modeling. Clinical
characteristics analyzed included history of diabetes mellitus, malignancy, intravenous drug use, or
underlying skin disease, and patient report of pain, burning or itching. Physical exam findings
included presence of bilateral disease, anatomic site of disease, presence of warmth, erythema,
tenderness, and/or swelling, body temperature, and heart rate on presentation. Laboratory values
included white blood cell count, neutrophil count, eosinophil count, ESR, CRP, CK, and LDH at the
time of initial work-up. Of 416 cases which met the study inclusion criteria, 340 cases were found to
be true cellulitis, and 76 cases were concluded to have alternative diagnoses after initial inpatient
treatment for cellulitis. The most common diseases initially mistaken as cellulitis were stasis dermatitis
(15), hematoma (6), and gout (5). Lack of bilaterality and presence of elevated body temperature
(greater than 100.4 F at admission) were found to be significant predictors of true cellulitis (p¼ 0.04,
p¼ 0.008 respectively). These characteristics and the other statistically significant predictors of true
cellulitis found in this analysis will be used to propose diagnostic guidelines to be used in future
prospective studies. The discussion will highlight the prevalence and types of skin conditions
mimicking cellulitis and alert the practitioner to common pitfalls in misdiagnosis.
5
Duration of voriconazole exposure: An independent risk factor for skin cancer
post-lung transplantation
1 - Margaret L. Spratt, MS / 2 - Bianca D. Lemos, MD / 3 - Emir Veledar, PhD / 4 - Clint Lawrence,
MD / 5 - G. Marshall Lyon, MD / 6 - Suephy C. Chen, MD, MS / 7- Fiona O. Zwald, MD 1, 2,
3 - Department of Dermatology, Emory University / 4, 5 - Department of Medicine and Division
of Transplantation, Emory University / 6 - Department of Dermatology, Emory University; Health
Services Research & Development Service, Atlanta VA Medical Center / 7 - Department of
Dermatology and Division of Transplantation, Emory University
Recent publications suggest that prolonged exposure to voriconazole is associated with an
increased risk of developing squamous cell carcinoma. We sought to determine whether there is
an association between the duration of voriconazole therapy and the number of skin cancers post-
lung transplantation. – A telephone-based survey and a chart review was performed for all living
patients who received a lung transplant at Emory University from 1993-2009. 65.9% (60 of 91) of
subjects were exposed to voriconazole for at least three months (11.2 ± 8.7 months; range 3-58
months) post-lung transplantation. 33.0% (30 of 91) of subjects had a history of skin cancer; 11
(12.1%) had skin cancer prior to transplant. By univariate analysis, time since transplant (r ¼
0.514), age (r ¼ 0.438), and high lifetime sun exposure (r ¼ 0.211) were correlated with the
number of skin cancers post-transplant. Skin type V/VI were protective (r ¼ -0.353). In
multivariate regression, time since transplant (0.061 per month), age (0.151 per year), skin
type I/II (4.939), and months of exposure to voriconazole (0.149) were found to be independent
risk factors for number of skin cancers post-lung transplantation. Duration of voriconazole
exposure correlates with increasing number of skin cancers post-lung transplantation. All patients
exposed to voriconazole should be educated about their increased risk of skin cancer,
and they should have regular dermatology follow-up for skin cancer screening. Physicians caring
for lung-transplant recipients should consider alternatives to voriconazole in patients at risk for
skin cancer.
6
Severe psoriasis impacts reclassification of ten-year framingham cardiovascular risk
1-Y. Yu/2-P. Krishnamoorthy/3-R. Pinnelas/4-D.B. Shin/5-A.B. Troxel/6-N.N. Mehta/7-J.M.
Gelfand, University of Pennsylvania, Philadelphia, PA
Psoriasis is a common inflammatory skin disease and is associated with systemic comorbidities such as
metabolic syndrome, diabetes mellitus, and cardiovascular (CV) disease. Recent evidence suggests that
psoriasis, especially if severe, is an independent risk factor for major adverse cardiac events (MACE)
such as myocardial infarction, stroke and CV related death. However, traditional risk stratification tools
such as the Framingham Risk Score (FRS) may underestimate long term MACE risk in this population.
Thus, the ideal approach for risk stratification and lipid treatment in psoriasis is unknown. In a recent
EULAR consensus statement, it was recommended that traditional risk estimates for patients with
rheumatoid and psoriatic arthritis be multiplied by 1.5 given the risk of CV disease. We sought to
quantify the effect of psoriasis on ten-year FRS and demonstrate how this impacts CV risk
reclassification in a clinical practice. We enrolled consecutive patients in a Preventive Cardiology
practice dedicated to psoriasis. We calculated the attributable risk (AR) of psoriasis on MACE to be
6.5% from the General Practice Research Database, a validated, population-based study. CV risk was
estimated using ten-year FRS based on total cholesterol before and after considering psoriasis AR, and
risk categories were based on lipid guidelines. A total of 103 patients (45±17 years, 60% male, 48%
hypertension, 36% tobacco use, 10% diabetes) were enrolled. Despite having a higher than expected
prevalence of established risk factors, our patients were at low risk (o10%) for 10-year CV events (male
mean FRS 8.3± 9.25, female 5.8± 5.81) given their young age. After adding the 6.5% from psoriasis
AR (male FRS 14.77± 9.25, female 12.26± 5.81), 50.5% of the entire sample was reclassified to a
higher-risk category. A total of 48% of males (n¼ 31) and 49% of females (n¼ 19) moved from low to
intermediate risk, and 3% (n¼ 2) of males moved from intermediate to high risk. Overall, this would
have resulted in a change of treatments and goals in half of the clinic patients per CV guidelines. FRS
may underestimate CV risk in this young sample of psoriasis patients. When considering the AR of
psoriasis on MACE, a significant portion of patients were reclassified into a higher risk category thereby
changing treatment goals. Larger population-based studies are needed to confirm these findings.
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